HealthDay News — Recommendations for the diagnosis and management of severe acquired aplastic anemia are presented in a clinical practice guideline issued by the American Society of Hematology and ...
Additional population-based studies of autoimmune hemolytic anemia and its management are needed to reduce mortality in this patient population. Autoimmune hemolytic anemia (AIHA) is typically a ...
The American Society of Hematology (ASH) released guidelines on the diagnosis and management of severe acquired aplastic anemia, a rare and life-threatening bone marrow failure disorder. The ...
While mild anemia is generally treatable, some severe forms, like thalassemia and aplastic anemia, can lead to life-threatening complications if untreated due to the body’s organs not receiving enough ...
Hypomethylating agents are standard in MDS treatment, with new drugs like Rytelo enhancing anemia management. Targeted therapies for IDH1/IDH2 mutations offer promising options, though challenges in ...
A new guideline from the Kidney Disease: Improving Global Outcomes (KDIGO) group provides updated recommendations on the management of anemia in chronic kidney disease (CKD), reflecting substantial ...
Anemia in myelofibrosis significantly affects survival and quality of life, with severe anemia reducing median survival fourfold compared to non-anemic patients. Transfusion dependency in ...
Hosted on MSN
Anemia of Chronic Disease: What to Know
Found in Some People With Long-Term Conditions That Involve Inflammation Medically reviewed by Gagandeep Brar, MD Anemia of chronic disease is a type of anemia caused by inflammation from long-term ...
The medication a doctor prescribes to treat anemia depends on the type of anemia a person has. For example, a person can take supplements to treat nutrient-deficiency anemia. More severe or chronic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results